Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | MPO | P05164 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | KDM5A | P29375 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31340325 | 0.77 | MAP2K1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL31340197 | 0.77 | MAP2K1 (0.31) | — | |
| SCHEMBL10367708 | 0.74 | CHRM3 (0.36) | ALDH1A1LMNACYP3A4KDM4EMAPT | |
| Hydrochloric Acid SCHEMBL31340297 | 0.72 | MMP2 (0.42) | ALDH1A1 | |
| SCHEMBL10366235 | 0.68 | ALDH1A1 (0.43) | ALDH1A1LMNAGAAMAPT | |
| SCHEMBL10829313 | 0.66 | LMNA (0.40) | LMNAMAPT | |
| SCHEMBL10366139 | 0.65 | SRD5A2 (0.42) | ALDH1A1LMNAGAAKDM4EMAPT | |
| SCHEMBL28069751 | 0.64 | ALDH1A1 (0.33) | ALDH1A1LMNAP2RX7MPOCYP3A4 | |
| SCHEMBL10368421 | 0.64 | CES2 (0.42) | ALDH1A1GAAMAPT | |
| SCHEMBL17111088 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747250-A1 | KINASE INHIBITORS | The United States Of America, As Represented By The Secretary, Department of Health and Human Services (US) | 2026-05-27 | — | — | EP | disclosed |
| WO-2025019585-A1 | KINASE INHIBITORS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2025-01-23 | — | — | WO | disclosed |